BSE Live
Jan 22, 16:01Prev. Close
22.25
Open Price
22.00
Bid Price (Qty.)
21.25 (70)
Offer Price (Qty.)
22.25 (49)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Beryl Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.87 | 1.01 | 0.98 | -0.95 | 0.35 | |
| Net CashFlow From Operating Activities | 2.64 | 0.82 | 2.48 | -0.29 | 0.38 | |
| Net Cash Used In Investing Activities | -0.40 | -1.08 | -1.30 | 0.54 | 0.26 | |
| Net Cash Used From Financing Activities | -1.55 | 0.10 | -1.17 | -0.43 | -0.58 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.69 | -0.16 | 0.01 | -0.18 | 0.06 | |
| Cash And Cash Equivalents Begin of Year | 0.12 | 0.28 | 0.27 | 0.45 | 0.40 | |
| Cash And Cash Equivalents End Of Year | 0.81 | 0.12 | 0.28 | 0.27 | 0.45 |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y